Factors  	Factors  	 NNS	O
related  	related  	 VBN	O
to  	to  	 TO	O
prognosis  	prognosis  	 VB	O
of  	of  	 IN	O
refractory  	refractory  	 JJ	B-NP
glaucoma  	glaucoma  	 NN	I-NP
with  	with  	 IN	O
diode  	diode  	 JJ	O
laser  	laser  	 NN	O
transscleral  	transscleral  	 VBZ	O
cyclophotocoagulation  	cyclophotocoagulation  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
To  	To  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
predictive  	predictive  	 JJ	B-NP
factors  	factors  	 NNS	I-NP
of  	of  	 IN	I-NP
refractory  	refractory  	 JJ	I-NP
glaucoma  	glaucoma  	 NNS	I-NP
treated  	treated  	 VBN	O
with  	with  	 IN	O
diode  	diode  	 FW	B-NP
laser  	laser  	 FW	I-NP
transscleral  	transscleral  	 FW	I-NP
cyclophotocoagulation  	cyclophotocoagulation  	 FW	I-NP
( 	( 	 -LRB-	O
TSCP 	TSCP 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
a  	a  	 DT	O
midterm  	midterm  	 JJ	B-NP
observation 	observation 	 NN	I-NP
.  	.  	 .	O
Fifty-four  	Fifty-four  	 JJ	O
consecutive  	consecutive  	 JJ	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
54  	54  	 CD	O
eyes 	eyes 	 NNS	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
refractory  	refractory  	 JJ	B-NP
glaucoma  	glaucoma  	 NN	I-NP
were  	were  	 VBD	O
enrolled  	enrolled  	 JJ	O
and  	and  	 CC	O
underwent  	underwent  	 VBD	O
TSCP  	TSCP  	 NNP	B-NP
( 	( 	 -LRB-	O
power  	power  	 NN	O
of  	of  	 IN	O
1.5-2.0  	1.5-2.0  	 NNP	O
W 	W 	 NNP	O
,  	,  	 ,	O
exposure  	exposure  	 NN	B-NP
time  	time  	 NN	I-NP
of  	of  	 IN	O
2  	2  	 CD	O
seconds  	seconds  	 NNS	O
and  	and  	 CC	O
20-50  	20-50  	 CD	O
applications 	applications 	 NNS	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
were  	were  	 VBD	O
regularly  	regularly  	 RB	O
followed  	followed  	 VBN	O
up  	up  	 RP	O
for  	for  	 IN	O
12  	12  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
Intraocular  	Intraocular  	 JJ	B-NP
pressure  	pressure  	 NN	I-NP
( 	( 	 -LRB-	O
IOP 	IOP 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
measured  	measured  	 VBN	O
before  	before  	 IN	O
TSCP  	TSCP  	 NNP	B-NP
treatment  	treatment  	 NN	I-NP
and  	and  	 CC	O
at  	at  	 IN	O
each  	each  	 DT	O
follow-up  	follow-up  	 JJ	B-NP
visit 	visit 	 NN	I-NP
.  	.  	 .	O
Patients  	Patients  	 NNS	O
were  	were  	 VBD	O
divided  	divided  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
sensitive  	sensitive  	 JJ	O
and  	and  	 CC	O
insensitive  	insensitive  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
TSCP  	TSCP  	 NNP	B-NP
on  	on  	 IN	O
IOP 	IOP 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
success  	success  	 NN	B-NP
rate  	rate  	 NN	I-NP
was  	was  	 VBD	O
defined  	defined  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
eyes  	eyes  	 NNS	O
achieving  	achieving  	 VBG	O
an  	an  	 DT	O
IOP  	IOP  	 NNP	B-NP
between  	between  	 IN	O
5  	5  	 CD	O
and  	and  	 CC	O
21  	21  	 CD	O
mm  	mm  	 CD	B-NP
Hg  	Hg  	 NNS	I-NP
following  	following  	 VBG	O
TSCP  	TSCP  	 NNP	B-NP
therapy  	therapy  	 NN	I-NP
at  	at  	 IN	O
their  	their  	 PRP$	O
final  	final  	 JJ	O
follow  	follow  	 NN	O
up  	up  	 IN	O
visit 	visit 	 NN	O
.  	.  	 .	O
Difference  	Difference  	 NN	O
of  	of  	 IN	O
age  	age  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
sensitive  	sensitive  	 JJ	O
and  	and  	 CC	O
insensitive  	insensitive  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
was  	was  	 VBD	O
evaluated  	evaluated  	 VBN	O
with  	with  	 IN	O
independent-samples  	independent-samples  	 JJ	B-NP
T  	T  	 NN	I-NP
test  	test  	 NN	I-NP
and  	and  	 CC	O
that  	that  	 IN	O
of  	of  	 IN	O
gender  	gender  	 JJ	B-NP
distribution  	distribution  	 NN	I-NP
of  	of  	 IN	O
two  	two  	 CD	O
groups  	groups  	 NNS	O
was  	was  	 VBD	O
evaluated  	evaluated  	 VBN	O
with  	with  	 IN	O
Fisher 	Fisher 	 NNP	O
's  	's  	 POS	O
exact  	exact  	 JJ	O
test 	test 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
success  	success  	 NN	B-NP
rate  	rate  	 NN	I-NP
of  	of  	 IN	O
different  	different  	 JJ	O
types  	types  	 NNS	O
of  	of  	 IN	O
glaucoma  	glaucoma  	 VBG	O
to  	to  	 TO	O
TSCP  	TSCP  	 NNP	B-NP
was  	was  	 VBD	O
calculated 	calculated 	 VBN	O
.  	.  	 .	O
A  	A  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
32  	32  	 CD	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
sensitive  	sensitive  	 JJ	O
to  	to  	 TO	O
TSCP  	TSCP  	 NNP	B-NP
( 	( 	 -LRB-	O
sensitive  	sensitive  	 JJ	B-NP
group 	group 	 NN	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
22  	22  	 CD	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
insensitive  	insensitive  	 VBN	O
to  	to  	 TO	O
TSCP  	TSCP  	 NNP	B-NP
( 	( 	 -LRB-	O
insensitive  	insensitive  	 JJ	B-NP
group 	group 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
success  	success  	 NN	B-NP
rates  	rates  	 NNS	I-NP
of  	of  	 IN	O
female  	female  	 JJ	O
( 	( 	 -LRB-	O
77.8 	77.8 	 NNP	O
% 	% 	 NN	O
,  	,  	 ,	O
14 	14 	 CD	O
/ 	/ 	 CD	O
18 	18 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
cases  	cases  	 NNS	O
being  	being  	 VBG	O
over  	over  	 IN	O
50  	50  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
71.4 	71.4 	 NNP	O
% 	% 	 NN	O
,  	,  	 ,	O
20 	20 	 CD	O
/ 	/ 	 CD	O
28 	28 	 CD	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
those  	those  	 DT	O
of  	of  	 IN	O
male  	male  	 JJ	O
( 	( 	 -LRB-	O
50.0 	50.0 	 NNP	O
% 	% 	 NN	O
,  	,  	 ,	O
18 	18 	 CD	O
/ 	/ 	 CD	O
36 	36 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
ones  	ones  	 NNS	B-NP
being  	being  	 VBG	O
under  	under  	 IN	O
50  	50  	 CD	O
years  	years  	 NNS	O
( 	( 	 -LRB-	O
46.2 	46.2 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
12 	12 	 CD	O
/ 	/ 	 CD	O
26 	26 	 CD	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
all  	all  	 DT	O
P 	P 	 NN	O
> 	> 	 CD	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
age  	age  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sensitive  	sensitive  	 JJ	O
and  	and  	 CC	O
insensitive  	insensitive  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
was  	was  	 VBD	O
56.0+ 	56.0+ 	 CD	O
/ 	/ 	 CD	O
-15.5  	-15.5  	 CD	O
and  	and  	 CC	O
46.4+ 	46.4+ 	 CD	O
/ 	/ 	 CD	O
-15.4  	-15.4  	 CD	O
years 	years 	 NNS	O
,  	,  	 ,	O
respectively  	respectively  	 RB	O
( 	( 	 -LRB-	O
P=0.029 	P=0.029 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
age  	age  	 NN	O
( 	( 	 -LRB-	O
P=0.029 	P=0.029 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
gender  	gender  	 JJ	B-NP
distribution  	distribution  	 NN	I-NP
( 	( 	 -LRB-	O
P=0.046 	P=0.046 	 NNP	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
groups  	groups  	 NNS	O
had  	had  	 VBD	O
significant  	significant  	 JJ	O
difference 	difference 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
success  	success  	 NN	B-NP
rate  	rate  	 NN	I-NP
of  	of  	 IN	I-NP
neovascular  	neovascular  	 JJ	I-NP
glaucoma 	glaucoma 	 NN	I-NP
,  	,  	 ,	O
primary  	primary  	 JJ	B-NP
angle-closure  	angle-closure  	 JJ	I-NP
glaucoma 	glaucoma 	 NN	I-NP
,  	,  	 ,	O
primary  	primary  	 JJ	O
open  	open  	 JJ	O
angle  	angle  	 NN	B-NP
glaucoma 	glaucoma 	 NN	I-NP
,  	,  	 ,	O
traumatic  	traumatic  	 JJ	O
glaucoma 	glaucoma 	 NN	O
,  	,  	 ,	O
uveitic  	uveitic  	 JJ	B-NP
glaucoma 	glaucoma 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
secondary  	secondary  	 JJ	B-NP
glaucoma  	glaucoma  	 NN	I-NP
after  	after  	 IN	O
silicone  	silicone  	 JJ	B-NP
oil  	oil  	 NN	I-NP
injection  	injection  	 NN	I-NP
to  	to  	 TO	O
TSCP  	TSCP  	 NNP	B-NP
was  	was  	 VBD	O
57.1 	57.1 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
100.0 	100.0 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
50.0 	50.0 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
20.0 	20.0 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
81.8 	81.8 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
0 	0 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Age 	Age 	 NN	O
,  	,  	 ,	O
gender 	gender 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
type  	type  	 NN	O
of  	of  	 IN	O
glaucoma  	glaucoma  	 NNS	O
appear  	appear  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
effect  	effect  	 NN	O
of  	of  	 IN	O
TSCP  	TSCP  	 NNP	B-NP
on  	on  	 IN	O
IOP  	IOP  	 NNP	B-NP
control 	control 	 NN	I-NP
.  	.  	 .	O
